nce good outcomes within 1 to 4 days after initiation of treatment. Treatment is usually started in divided doses of 250 mg twice a day, followed by 250 mg increments as needed and tolerated. Serum valproic acid levels can be used as a guide for dosing since side effects and risk of toxicity increase when supratherapeutic blood levels are maintained. Extended-release valproic acid can also be used, thereby improving compliance by means of once-a-day dosing. Side effects include tremor, alopecia, weight gain